MPITX Mutual Fund

NAV$19.56

Fund Essentials - as of May 31, 2026

Net Assets
$205M
Expense Ratio
0.87%
Dividend Yield (Current)
2.17%
Holdings
60
Inception Date
Oct 2, 2000
Fund Family
BNY Mellon Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+10.10%
1 Year+21.06%
3 Year+15.11%
5 Year+7.85%
10 Year+8.84%

Asset Allocation

Stocks: 99.14%
Cash: 0.86%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
ASML:ASASML HOLDING NV3.14%
SHEL:LNShell Plc ADR2.46%
0QR4:SMNestl S.A.2.43%
AZN:LNAstrazeneca Plc2.30%
SAN:PASanofi SA2.18%
Top 10 Concentration: 22.63%Report Date: May 31, 2026
Download all 60 holdings for MPITX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
2.17%
Frequency
Annually
Latest Distribution
$0.29
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how MPITX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

MPITX Mutual Fund Overview

MPITX Mutual Fund (BNY Mellon International Fund Class M Shares) is managed by BNY Mellon Investment Management with $205.2M in net assets. MPITX expense ratio is 0.87%, holding 60 positions across sectors including Unknown, Industrials, Energy. Inception date: 2000-10-02.

MPITX performance shows a YTD return of 10.10%. The 1-year return is 21.06% and the 5-year return is 7.85%. MPITX dividend yield stands at 2.17%, paid annually.

MPITX top holdings include ASML HOLDING NV (3.1%), Shell Plc ADR (2.5%), Nestl S.A. (2.4%), Astrazeneca Plc (2.3%), Sanofi SA (2.2%). View all MPITX holdings, sector breakdown, or dividend history.

MPITX can be compared against other funds using the overlap calculator or side-by-side comparison tool. MPITX alternatives are available via the screener, along with tax-loss harvesting opportunities.